Rejuvenate Bio
Reversing age-related decline — proven in animals, advancing to humans
https://wefunder.com/rejuvenatebio
Total raised on Wefunder: 440130
Total investors: 150
Quick facts
- Led by exited biotech entrepreneurs from Harvard, MIT, Duke, Princeton, and Caltech
- Co-founded by George Church, Harvard Medical School geneticist and TIME 100 scientist
- $130M+ in contracted development & commercial milestone payments across 6 animal health partnerships
- $5.1M in cumulative payments and in-kind services received from partners
- One-time injection gives years of treatment, with 2+ years of effect shown in dogs
- Radically cut manufacturing costs 10x to make doses accessible at $100/dose
- $250B+ market opportunity in the aging, metabolic & cardiac disease market
- $40M+ raised via nondilutive grants & investors: Digitalis, Kendall Capital Partners, & KdT Ventures